Cargando…

Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer

BACKGROUND: Trastuzumab has been prevailingly accepted as a beneficial treatment for gastric cancer (GC) by targeting human epidermal growth factor receptor 2 (HER2)-positive. However, the therapeutic resistance of trastuzumab remains a major obstacle, restricting the therapeutic efficacy. Therefore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Chaoran, Xue, Pei, Zhang, Luyang, Pan, Ruijun, Cai, Zhenhao, He, Zirui, Sun, Jing, Zheng, Minhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106878/ https://www.ncbi.nlm.nih.gov/pubmed/30134903 http://dx.doi.org/10.1186/s12957-018-1475-6

Ejemplares similares

Identification of Key Genes and Pathways Involved in Circulating Tumor Cells in Colorectal Cancer
por: Pan, Ruijun, et al.
Publicado: (2022)

Identification of key genes and pathways involved in microsatellite instability in colorectal cancer
por: Yu, Chaoran, et al.
Publicado: (2019)

Wnt/β-catenin pathway is a key signaling pathway to trastuzumab resistance in gastric cancer cells
por: Kim, Yuna, et al.
Publicado: (2023)

Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer
por: Yang, Guangda, et al.
Publicado: (2019)

A greater lymph node yield is required during pathological examination in microsatellite instability-high gastric cancer
por: Cai, Zhenghao, et al.
Publicado: (2021)

Corrigendum to “Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer”
por: Yang, Guangda, et al.
Publicado: (2020)

Co-expression network analysis identified specific miRNAs and genes in association with slow-transit constipation
por: Yu, Chaoran, et al.
Publicado: (2020)

METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST
por: Yang, Xiao, et al.
Publicado: (2020)

Prognostic value of the mRNA expression of gap junction α members in patients with gastric cancer
por: Zhao, Xuan, et al.
Publicado: (2019)

SFMBT1 facilitates colon cancer cell metastasis and drug resistance combined with HMG20A
por: Pan, Ruijun, et al.
Publicado: (2022)

Characterization of the prognostic values of the NDRG family in gastric cancer
por: Yu, Chaoran, et al.
Publicado: (2019)

N-myc downstream-regulated gene 1 promotes oxaliplatin-triggered apoptosis in colorectal cancer cells via enhancing the ubiquitination of Bcl-2
por: Yang, Xiao, et al.
Publicado: (2017)

Development of trastuzumab-resistant human gastric carcinoma cell lines and mechanisms of drug resistance
por: Zuo, Qiang, et al.
Publicado: (2015)

N-myc downstream-regulated gene 1 inhibits the proliferation of colorectal cancer through emulative antagonizing NEDD4-mediated ubiquitylation of p21
por: Zhang, Sen, et al.
Publicado: (2019)

ERBB2D16 Expression in HER2 Positive Gastric Cancer Is Associated With Resistance to Trastuzumab
por: Wang, Shuo, et al.
Publicado: (2022)

Resistance to Trastuzumab
por: Vivekanandhan, Sneha, et al.
Publicado: (2022)

A new mechanism of trastuzumab resistance in gastric cancer: MACC1 promotes the Warburg effect via activation of the PI3K/AKT signaling pathway
por: Liu, Jing, et al.
Publicado: (2016)

Prolonged neoadjuvant chemotherapy without radiation versus total neoadjuvant therapy for locally advanced rectal cancer: A propensity score matched study
por: Zhao, Xuan, et al.
Publicado: (2022)

Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer
por: Arienti, Chiara, et al.
Publicado: (2016)

Overexpression of GSE1 Related to Trastuzumab Resistance in Gastric Cancer Cells
por: Wang, Wenbin, et al.
Publicado: (2021)

Research on drug resistance mechanism of trastuzumab caused by activation of the PI3K/Akt signaling pathway
por: Chen, Xi, et al.
Publicado: (2013)

Metabolic pathways underlying GATA6 regulating Trastuzumab resistance in Gastric Cancer cells based on untargeted metabolomics
por: Chang, Jinxia, et al.
Publicado: (2020)

Transcriptome sequencing identifies key pathways and genes involved in gastric adenocarcinoma
por: Zhang, Wenhu, et al.
Publicado: (2018)

Prefoldin subunits (PFDN1–6) serve as poor prognostic markers in gastric cancer
por: Yesseyeva, Galiya, et al.
Publicado: (2020)

Synergistic antitumor effect of the anti-ErbB2 antibodies trastuzumab and H2-18 on trastuzumab-resistant gastric cancer cells
por: Wang, Chao, et al.
Publicado: (2021)

Involvement of kallikrein‐PAR2‐proinflammatory pathway in severe trastuzumab‐induced cardiotoxicity
por: Sasaki, Ritsuko, et al.
Publicado: (2022)

Identification of key pathways and genes in response to trastuzumab treatment in breast cancer using bioinformatics analysis
por: Zeng, Fanxin, et al.
Publicado: (2018)

Targeting Gastric Cancer with Trastuzumab: New Clinical Practice and Innovative Developments to Overcome Resistance
por: Roukos, Dimitrios H.
Publicado: (2009)

Nestin overexpression reduces the sensitivity of gastric cancer cells to trastuzumab
por: Wei, Yi-Chou, et al.
Publicado: (2023)

Target Points in Trastuzumab Resistance
por: Shojaei, Sahar, et al.
Publicado: (2012)

A novel knotless hand-sewn end-to-end anastomosis using V-loc barbed suture vs. stapled anastomosis in laparoscopic left colonic surgery: A propensity scoring match analysis
por: Xu, Shining, et al.
Publicado: (2022)

Emerging Targeted Therapies for HER2 Positive Gastric Cancer That Can Overcome Trastuzumab Resistance
por: Mitani, Seiichiro, et al.
Publicado: (2020)

Trastuzumab-induced thrombocytopenia after eight cycles of trastuzumab treatment
por: Zhou, Qiong, et al.
Publicado: (2020)

Targeting HER3 or MEK overcomes acquired Trastuzumab resistance in HER2-positive gastric cancer-derived xenograft
por: Zhang, Mengqi, et al.
Publicado: (2022)

Identification of the key differentially expressed genes and pathways involved in neutrophilia
por: He, Chengcheng, et al.
Publicado: (2019)

Autophagy flux inhibition augments gastric cancer resistance to the anti-human epidermal growth factor receptor 2 antibody trastuzumab
por: Ye, Hua, et al.
Publicado: (2018)

Quantitative proteomics profiling reveals activation of mTOR pathway in trastuzumab resistance
por: Liu, Wenhu, et al.
Publicado: (2017)

Cardiology Involvement in Patients With Breast Cancer Treated With Trastuzumab
por: Demissei, Biniyam G., et al.
Publicado: (2020)

Exploring potential molecular resistance and clonal evolution in advanced HER2-positive gastric cancer under trastuzumab therapy
por: Xu, Qi, et al.
Publicado: (2023)

Trastuzumab Resistance: Role for Notch Signaling
por: Mehta, Kinnari, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_rmq6lbd0liaqpvpm4q9dv96es5